Laura Kayani joined the corporate and private equity transactions department of Ropes & Gray’s London office in 2017. Prior to joining the firm, Laura was an associate in the corporate team of a large international law firm.

Laura has a wide range of experience advising clients on domestic and international M&A transactions and providing general corporate law advice, with particular experience of acting for private equity investors, management teams and portfolio companies on investments, acquisitions, disposals and restructurings.

Experience

  • Advised Avista Healthcare Partners on its:
    • acquisition of Terrats Medical, a leading global provider of dental prosthetics, including abutments and implants, from Miura Partners
    • joint acquisition with VHC Investco of Vision Healthcare, one of Europe’s fastest-growing omni-channel and direct-to-consumer health care companies
    • sale of Trimb Healthcare, a leading consumer health care company based in Stockholm, for SEK 3.4 billion 
  • Advised Partners Group on:
    • acting on behalf of its clients, the agreement to invest in Exus, a leading European infrastructure asset management firm focused on the renewable energy sector. Partners Group plans to commit up to EUR 1 billion in growth capital
    • its acquisition of Pharmathen, a European pharmaceutical company, from international investment firm BC Partners on behalf of its clients. The transaction values Pharmathen at an enterprise value of around EUR1.6 billion 
    • its acquisition of a major equity stake in Rovensa, a leading Portuguese-headquartered provider of specialty crop nutrition, biocontrol and protection products, from Bridgepoint
  • Advised Advent International and its portfolio company NIQ on the strategic combination with GfK (resulting in the world's leading consumer intelligence company) and the associated divestment of GfK's consumer panel business to YouGov
  • Advised Astorg on the demerger of Fastmarkets from Delinian, formerly known as Euromoney Institutional Investor plc
  • Advised Bridgepoint on its acquisition of Monica Vinader Limited, an award-winning British demi-fine luxury jewellery brand
  • Advised Avista Healthcare Partners and Nordic Capital and Swiss pharmaceutical company Acino on the sale of Acino to ADQ
  • Advised Pulsant, one of the leading nationwide providers of data centre and cloud infrastructure in the UK, on its sale from Oak Hill Capital and Scottish Equity Partners to Antin Infrastructure Partners 
  • Advised 3i Group plc on its c. £125 million investment alongside management for a majority stake in MPM, an international leader in branded, premium, natural pet food 
  • Advised Axcel on its acquisition of Phase One, a technology business specialising in high-end digital imaging software and equipment
  • Advised Epiris on:
    • its acquisition of Diamorph AB (publ), a supplier of advanced material solutions, from shareholders including Serendipity Group and Investment AB Latour (publ) as majority shareholders
    • its acquisition of Bonhams, the global auction house, from private shareholders
  • Acting for Ares Management on the sale of its portfolio company Cordium – a leading provider of governance, risk and compliance services – to ACA Compliance Group

Areas of Practice

    Disclaimer

    Ropes & Gray International LLP is a limited liability partnership registered in Delaware, United States of America and is a recognised body regulated by the Solicitors Regulation Authority (with registered number 521000).